scispace - formally typeset
E

Erik B. Pedersen

Researcher at University of Southern Denmark

Publications -  540
Citations -  6400

Erik B. Pedersen is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Oligonucleotide & Nucleic acid. The author has an hindex of 38, co-authored 537 publications receiving 6088 citations. Previous affiliations of Erik B. Pedersen include Iuliu Hațieganu University of Medicine and Pharmacy & King Saud University.

Papers
More filters
Journal ArticleDOI

Intercalating nucleic acids containing insertions of 1-O-(1-pyrenylmethyl)glycerol: stabilisation of dsDNA and discrimination of DNA over RNA

TL;DR: Fluorescence measurements show a stronger interaction of the pyrene moiety with DNA than with RNA, indicating intercalation as the stabilising factor in DNA/INA duplexes.
Journal ArticleDOI

ESR characterization of trans-diacidatotetrakis(pyridine)vanadium and -manganese trans-VII(py)4X2 and trans-MnII(py)4X2 (X = NCS, Cl, Br, I; py = pyridine)

TL;DR: In this paper, the general formula trans-M II (py) 4 X 2 (M II =V, Mn, Fe, Co, Ni, Ru; X=NCS, Cl, Br, I) has been synthesized and all compounds prepared have been characterized by means of X-ray powder diffraction and thereby space groups and unit cell parameters have been obtained in most cases
Journal ArticleDOI

Synthesis and Anti-HIV-1 Activity of Novel 2,3-Dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones

TL;DR: Appropriately substituted 2,3-dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones 9-12 and 18 were considered as annulated analogues of HEPT (1-[(2-hydroxyethoxyethoxy)methyl]-6-(phenylthio)-thymine), and some of these compounds were also found active against HIV-1.
Journal ArticleDOI

Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.

TL;DR: This review discusses the properties of the FDA-approved NNRTI drugs and focuses on the recent efforts being made to produce second generation inhibitors that circumvent this resistance problem.
Journal ArticleDOI

S-Glucosylated hydantoins as new antiviral agents

TL;DR: In antiviral studies the most active compounds against both HSV-1 andHSV-2 were 5-(2-thienylmethylene)-3-phenyl-2-(2,3,4,6- tetra-O-acetyl-beta-D-glucopyranosyl)-2-Thiohydantoin and 5-3 glucosylated hydantoins.